Malgorzata Wasacz
Medical College of Rzeszow University, PolandPresentation Title:
The importance of QEEG in diagnosing and evaluating the effectiveness of EEG biofeedback therapy in children with mild autism spectrum disorder, revealing attention deficit disorder
Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by complex and multifactorial causes, making it difficult to diagnose, especially during early childhood. One promising technique is Quantitative Electroencephalography (QEEG), which can be used to assess brainwave activity. This study examined brainwave changes in children with mild ASD and attention deficit issues, focusing on the potential benefits of biofeedback (neurofeedback) therapy. The goal was to evaluate brainwave amplitudes before and after therapy, using QEEG as the primary tool. The findings showed significant changes in brainwave activity following biofeedback therapy. Delta wave amplitudes were significantly reduced, particularly in the frontal region (Fz), with notable changes also observed in the central areas of the brain (Cz, C3, C4). SMR wave activity, particularly in the frontal cortex (Fz), also showed significant reduction post-therapy. Biofeedback therapy demonstrates effectiveness in reducing Delta and Beta1 wave amplitudes in children with ASD.
Biography
Malgorzata Wasacz has a master's degree in psychology in management. She graduated from the Jagiellonian University in Krakow. She works at the University of Rzeszów as an assistant. Her professional interests are based mainly on communication between medical personnel and relationships in the medical team, as well as communication with the patient.
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Drop us an email for Program enquiry
neuralscience@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
General Queries
contact@scientexconferences.com
neuralscience@scientexconference.org
Our Social Presence
Call us at
USA :(+1) 689 303 3812